Acro Biomedical Co., Ltd.
ACBM
$0.03
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.90K | 4.10K | 4.30K | 0.00 | 300.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 10.00K | -- | 35.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 4.60K | 4.60K |
| Total Current Assets | 3.90K | 14.10K | 4.30K | 39.60K | 4.90K |
|
|
|||||
| Total Current Assets | 3.90K | 14.10K | 4.30K | 39.60K | 4.90K |
| Net Property, Plant & Equipment | -- | -- | -- | 13.70K | 20.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 3.90K | 14.10K | 4.30K | 53.30K | 25.20K |
|
|
|||||
| Total Accounts Payable | 56.00K | 55.60K | 116.60K | 95.50K | 143.20K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 375.10K | 325.50K | 300.40K | 241.70K | 147.90K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 13.70K | 18.00K |
| Total Finance Division Other Current Liabilities | -- | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Other Current Liabilities | -- | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Current Liabilities | 431.10K | 401.10K | 436.90K | 370.80K | 329.10K |
|
|
|||||
| Total Current Liabilities | 431.10K | 401.10K | 436.90K | 370.80K | 329.10K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 375.10K | 325.50K | 300.40K | 241.70K | 147.90K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 431.10K | 401.10K | 436.90K | 370.80K | 329.10K |
|
|
|||||
| Common Stock & APIC | 32.38M | 32.37M | 32.37M | 32.37M | 32.36M |
| Retained Earnings | -32.80M | -32.76M | -32.80M | -32.68M | -32.67M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -427.20K | -387.00K | -432.60K | -317.50K | -303.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -427.20K | -387.00K | -432.60K | -317.50K | -303.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -427.20K | -387.00K | -432.60K | -317.50K | -303.90K |
|
|
|||||